BAL PHARMA LTD. Peer Comparison
BALPHARMA · Healthcare · Current price ₹85.59
Peers tracked
11
BAL PHARMA LTD. P/E
21.7x
Sector
Healthcare
BAL PHARMA LTD. vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,931.7 | 39.1x | 4,63,573 |
| DIVI S LABORATORIES LTD | ₹9,220 | 69.1x | 2,44,771 |
| TORRENT PHARMACEUTICALS L | ₹5,012 | 72.9x | 1,69,673 |
| ZYDUS LIFESCIENCES LTD | ₹1,154.2 | 22.0x | 1,15,132 |
| CIPLA LTD | ₹1,412.8 | 30.3x | 1,14,112 |
| LAURUS LABS LIMITED | ₹1,864 | 92.8x | 1,00,536 |
| MANKIND PHARMA LIMITED | ₹2,391.5 | 53.7x | 98,741 |
| LUPIN LIMITED | ₹2,155.2 | 20.6x | 98,536 |
| DR. REDDY S LABORATORIES | ₹1,156.5 | 26.8x | 96,525 |
| AUROBINDO PHARMA LTD | ₹1,648.2 | 25.9x | 95,729 |
| BAL PHARMA LTD. | ₹85.65 | 19.9x | 141 |
BAL PHARMA LTD. versus its peers
BAL PHARMA LTD. operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 21.7x may be cheap in one industry and expensive in another.
More on BAL PHARMA LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.